Second clinical trial: Istituto Dermopatico dell’Immacolata, Rome
In the second trial, at Istituto Dermopatico dell’Immacolata, the MBS AST-POCT analyses were performed only on culture-positive samples, i.e., on samples for which urine culture and AST results were made available by the hospital’s laboratory. Analyses were performed on frozen samples, allowing the possibility to expand the pool pf patients tested and to obtain statistically significant results.